Filing Details

Accession Number:
0001181431-10-000527
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-04 12:00:00
Reporting Period:
2009-12-30
Filing Date:
2010-01-04
Accepted Time:
2010-01-04 17:19:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1174940 Oragenics Inc ORNI Pharmaceutical Preparations (2834) 593410522
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1234877 Beverly Koski 1500 West University Parkway
Sarasota FL 34243
No No Yes No
1234878 L Christine Koski 1500 West University Parkway
Sarasota FL 34243
Yes No Yes No
1234879 Koski Family Lp 1500 West University Parkway
Sarasota FL 34243
No No Yes No
1234880 C Robert Koski 1500 West University Parkway
Sarasota FL 34243
Yes No Yes No
1234881 L Thomas Koski 1500 West University Parkway
Sarasota FL 34243
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2009-12-30 5,000,000 $0.25 48,960,000 No 4 P Direct
Common Stock Acquisiton 2009-12-30 4,000,000 $0.25 52,960,000 No 4 P Direct
Common Stock Acquisiton 2009-12-30 1,000,000 $0.10 53,960,000 No 4 X Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 X Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants Disposition 2009-12-30 1,000,000 $0.00 1,000,000 $0.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-06-29 2014-06-28 No 4 X Direct
Footnotes
  1. Shares acquired from the issuer in a private placement on December 30, 2009.
  2. Shares owned directly by Koski Family Limited Partnership. Shares owned indirectly by Beverly Koski (through Koski Management, Inc.), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
  3. Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
  4. Shares acquired pursuant to conversion of a secured promissory note dated as of June 29, 2009 in the principal amount of $1,000,000 at the exchange rate of $0.25 per share.